Royal Bank of Canada
LEGN icon

Royal Bank of Canada’s Legend Biotech LEGN Stock Holding History

Royal Bank of Canada’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$929K Buy
32,184
+7,923
+33% +$214K ﹤0.01% 3890
2026
Q1 		$439K Buy
24,261
+2,611
+12% +$49.8K ﹤0.01% 4236
2025
Q4 		$471K Sell
21,650
-35,167
-62% -$1.01M ﹤0.01% 4212
2025
Q3 		$1.85M Buy
56,817
+21,496
+61% +$794K ﹤0.01% 3465
2025
Q2 		$1.25M Buy
35,321
+35,021
+11,674% +$1.13M ﹤0.01% 3703
2025
Q1 		$10K Sell
300
-499
-62% -$17.9K ﹤0.01% 6158
2024
Q4 		$26K Sell
799
-724
-48% -$30K ﹤0.01% 6002
2024
Q3 		$74K Sell
1,523
-1,520
-50% -$81K ﹤0.01% 5516
2024
Q2 		$135K Sell
3,043
-957
-24% -$44.1K ﹤0.01% 5067
2024
Q1 		$224K Buy
4,000
+3,900
+3,900% +$235K ﹤0.01% 4596
2023
Q4 		$6K Sell
100
-468
-82% -$29.7K ﹤0.01% 6620
2023
Q3 		$38K Buy
568
+554
+3,957% +$38.5K ﹤0.01% 5923
2023
Q2 		$1K Buy
+14
New +$915 ﹤0.01% 7024
2023
Q1 		– Sell
-18
Closed -$1K – 7283
2022
Q4 		$1K Hold
18
– – ﹤0.01% 7044
2022
Q3 		$1K Buy
+18
New +$845 ﹤0.01% 7212
2021
Q3 		– Sell
-41
Closed -$2K – 7749
2021
Q2 		$2K Buy
+41
New +$1.39K ﹤0.01% 7250

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Royal Bank of Canada's LEGN Position: Q2 2026 in Review

Royal Bank of Canada increased its Legend Biotech (LEGN) stake by 33% in Q2 2026, buying an estimated $214K and bringing the position to 32,184 shares worth $929K. The position accounts for ﹤0.01% of the portfolio, ranked #3890.

Royal Bank of Canada first reported a position in LEGN in Q2 2021 and has held it in 16 quarters since. The position peaked at $1.85M in Q3 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Royal Bank of Canada held 32,184 shares of Legend Biotech worth $929K as of Q2 2026.
  • Royal Bank of Canada bought 7,923 Legend Biotech shares in Q2 2026, an estimated $214K.
  • Legend Biotech made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #3890 holding.
  • Royal Bank of Canada first reported a position in Legend Biotech in Q2 2021 and has held it in 16 quarters since.
  • Royal Bank of Canada's Legend Biotech position peaked at $1.85M in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.